Advertisement
Screener

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Form 6-K: Report of foreign private issuer, 2021

1.8 / 5 stars · 14/40 Roast Me

Add as a preferred source on Google

SCINAI IMMUNOTHERAPEUTICS LTD. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2021-12-30: Form 6-K; Period of report 2021-12-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea153246-6k_biondvaxpharma.htm.
  • 2021-12-29: Form 6-K; Period of report 2021-12-29; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea153120-6k_biondvaxpharma.htm.
  • 2021-12-27: Form 6-K; Period of report 2021-12-27; Description CURRENT REPORT; Document ea153083-6k_biondvax.htm.
  • 2021-12-27: Form 6-K/A; Period of report 2021-09-30; Description AMENDMENT NO. 1 TO FORM 6-K; Document ea153034-6ka1_biond.htm.
FiledFormPeriod of reportDescriptionDocument
2021-12-306-K2021-12-30REPORT OF FOREIGN PRIVATE ISSUERea153246-6k_biondvaxpharma.htm
2021-12-296-K2021-12-29REPORT OF FOREIGN PRIVATE ISSUERea153120-6k_biondvaxpharma.htm
2021-12-276-K2021-12-27CURRENT REPORTea153083-6k_biondvax.htm
2021-12-276-K/A2021-09-30AMENDMENT NO. 1 TO FORM 6-Kea153034-6ka1_biond.htm
2021-12-226-K2021-12-22REPORT OF FOREIGN PRIVATE ISSUERea152900-6k_biondvax.htm
2021-12-136-K2021-12-13REPORT OF FOREIGN PRIVATE ISSUERea152223-6k_biondvax.htm
2021-12-026-K2021-12-02FORM 6-Kea151533-6k_biondvax.htm
2021-11-246-K2021-11-24CURRENT REPORTea151384-6k_biondvax.htm
2021-11-226-K2021-11-22REPORT OF FOREIGN PRIVATE ISSUERea151013-6k_biondvaxpharma.htm
2021-11-126-K2021-11-12REPORT OF FOREIGN PRIVATE ISSUERea150490-6k_biondvax.htm
2021-10-256-K2021-10-24REPORT OF FOREIGN PRIVATE ISSUERea149305-6k_biondvax.htm
2021-08-266-K2021-08-26REPORT OF FOREIGN PRIVATE ISSUERea146517-6k_biondvax.htm
2021-06-236-K2021-06-23REPORT OF FOREIGN PRIVATE ISSUERea143152-6k_biondvax.htm
2021-05-136-K2021-05-13REPORT OF FOREIGN PRIVATE ISSUERea140825-6k_biondvax.htm
2021-04-066-K2021-04-06REPORT OF FOREIGN PRIVATE ISSUERea139094-6k_biondvax.htm
2021-03-236-K2021-03-23CURRENT REPORTea138226-6k_biondvax.htm
2021-03-226-K2021-03-22REPORT OF FOREIGN PRIVATE ISSUERea138186-6k_biondvax.htm
2021-03-166-K2021-03-16REPORT OF FOREIGN PRIVATE ISSUERea137782-6k_biondvaxpharma.htm
2021-03-046-K2021-03-04REPORT OF FOREIGN PRIVATE ISSUERea136999-6k_biondvax.htm
2021-02-246-K2021-02-24FORM 6-Kea136416-6k_biondvax.htm
2021-02-176-K2021-02-17REPORT OF FOREIGN PRIVATE ISSUERea135920-6k_biondvax.htm
2021-02-116-K2021-02-10REPORT OF FOREIGN PRIVATE ISSUERea135125-6k_biondvax.htm
2021-02-086-K2021-02-08CURRENT REPORTea134888-6k_biondvax.htm
2021-02-026-K2021-02-02REPORT OF FOREIGN PRIVATE ISSUERea134396-6k_biondvaxpharma.htm
2021-02-026-K2021-02-01REPORT OF FOREIGN PRIVATE ISSUERea134267-6k_biondvax.htm
2021-01-296-K2021-01-29REPORT OF FOREIGN PRIVATE ISSUERea134200-6k_biondvax.htm
2021-01-296-K2021-01-28REPORT OF FOREIGN PRIVATE ISSUERea134189-6k_biondvax.htm
2021-01-286-K2020-09-30REPORT OF FOREIGN PRIVATE ISSUERea134115-6k_biondvaxpharma.htm
2021-01-216-K2021-01-21REPORT OF FOREIGN PRIVATE ISSUERea133691-6k_biondvaxpharma.htm
Advertisement